CAT

E130569

The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for assessing advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.

All labels observed (1)

Label Occurrences
CAT canonical 3

How this entity was disambiguated

Statements (46)

Predicate Object
instanceOf European Union agency body
regulatory body
scientific committee
abbreviation CAT self-linksurface differs
country European Union
domain advanced therapy medicinal products
gene therapy
regenerative medicine
somatic cell therapy
tissue-engineered products
formedBy European Union policy
surface form: European Union legislation
hasAcronym CAT self-linksurface differs
hasMemberType members appointed by the European Commission
members nominated by EU Member States
scientific experts
inception 2009
jurisdiction European Union
languageOfWorkOrName English
legalBasis Regulation (EC) No 1394/2007
Regulation (EC) No 726/2004
locatedIn Amsterdam
Netherlands
parentOrganization European Medicines Agency
partOf European Medicines Agency
providesGuidanceOn clinical trials of advanced therapies
development of advanced therapy medicinal products
quality and safety requirements for advanced therapies
regulates advanced therapy medicinal products in the EU
role advises on certification of quality and non-clinical data for advanced therapies
advises on classification of advanced therapy medicinal products
assesses advanced therapy medicinal products
prepares draft opinions on advanced therapy medicinal products
provides scientific expertise on advanced therapies
supports development of advanced therapy medicinal products in the EU
subjectOf European Medicines Agency documentation
supervises evaluation of marketing authorisation applications for advanced therapy medicinal products
topic biotechnology
gene and cell therapies
medicines regulation
typeOfAdvancedTherapiesAssessed gene therapy medicinal products
somatic cell therapy medicinal products
tissue-engineered products
website https://www.ema.europa.eu/en/committees/committee-advanced-therapies-cat
worksWith Committee for Medicinal Products for Human Use
Committee for Orphan Medicinal Products
Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
surface form: Pharmacovigilance Risk Assessment Committee

How these facts were elicited

Referenced by (3)

Full triples — surface form annotated when it differs from this entity's canonical label.

CAT abbreviation CAT self-linksurface differs
subject surface form: Committee for Advanced Therapies
CAT hasAcronym CAT self-linksurface differs
subject surface form: Committee for Advanced Therapies